Phospho-JNK (Tyr185) Recombinant antibody
Phospho-JNK (Tyr185) Recombinant Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Human, mouse and More (3)
Cat no : 80024-1-RR
|Positive WB detected in||HEK-293T cells, UV treated NIH/3T3 cells, UV treated HEK-293T cells, Anisomycin treated NIH/3T3 cells, Calyculin A treated HEK-293T cells|
|Western Blot (WB)||WB : 1:1000-1:4000|
|Sample-dependent, check data in validation data gallery|
80024-1-RR targets Phospho-JNK (Tyr185) in WB, ELISA applications and shows reactivity with Human, mouse samples.
|Tested Reactivity||Human, mouse|
|Cited Reactivity||human, mouse, rat, pig|
|Host / Isotype||Rabbit / IgG|
|Full Name||mitogen-activated protein kinase 8|
|Observed molecular weight||37-45kDa|
|GenBank accession number||NM_139049|
|Gene ID (NCBI)||5599|
|Purification Method||Protein A purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
MAPK8(Mitogen-activated protein kinase 8) is also named as JNK1, PRKM8, SAPK1, SAPK1C and belongs to the MAP kinase subfamily. MAPK8 is activated by dual phosphorylation at a Thr-Pro-Tyr motif during response to UV light. Phosphorylation of these sites in response to UV results in transcriptional activation of c-Jun.
|Product Specific Protocols|
|WB protocol for Phospho-JNK (Tyr185) antibody 80024-1-RR||Download protocol|
|Click here to view our Standard Protocols|
FUT2-dependent fucosylation of HYOU1 protects intestinal stem cells against inflammatory injury by regulating unfolded protein response
Br J Pharmacol
Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A
J Hazard Mater
Prenatal exposure to environmentally relevant levels of PBDE-99 leads to testicular dysgenesis with steroidogenesis disorders.
J Transl Med
Angiotensin-(1-7) ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response and mitochondrial damage through the NF-κB and MAPK pathways
The GSTP1/MAPKs/BIM/SMAC modulatory actions of nitazoxanide: Bioinformatics and experimental evidence in subcutaneous solid Ehrlich carcinoma-inoculated mice
Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways.